Abstract

Concentrations of extracellular glycine in the central nervous system are regulated by Na(+)/Cl(-)-dependent glycine transporters, GLYT1 and GLYT2. N-Arachidonylglycine (NAGly) is an endogenous inhibitor of GLYT2 with little or no effect on GLYT1 and is analgesic in rat models of neuropathic and inflammatory pain. Understanding the molecular basis of NAGly interactions with GLYT2 may allow for the development of novel therapeutics. In this study, chimeric transporters were used to determine the structural basis for differences in NAGly sensitivity between GLYT1 and GLYT2 and also the actions of a series of related N-arachidonyl amino acids. Extracellular loops 2 and 4 of GLYT2 are important in the selective inhibition of GLYT2 by NAGly and by the related compounds N-arachidonyl-gamma-aminobutyric acid and N-arachidonyl-d-alanine, whereas only the extracellular loop 4 of GLYT2 is required for N-arachidonyl-l-alanine inhibition of transport. These observations suggest that the structure of the head group of these compounds is important in determining how they interact with extracellular loops 2 and 4 of GLYT2. Site-directed mutagenesis of GLYT2 EL4 residues was used to identify the key residues Arg(531), Lys(532), and Ile(545) that contribute to the differences in NAGly sensitivity.

Highlights

  • N-Arachidonylglycine (NAGly)4 is an endogenous derivative of arachidonic acid that is produced in highest concentrations in the spinal cord [7]

  • GLYT2 contains a significantly larger extracellular loop 2 (EL2) than GLYT1, and we hypothesized that this loop may contain structural features that mediate the actions of NAGly

  • Is a Noncompetitive Inhibitor of GLYT2—The aim of this study was to investigate the molecular basis for the differences in N-arachidonyl-amino acids (NAAAs) inhibition between the human glycine transporters GLYT1 and GLYT2

Read more

Summary

Introduction

N-Arachidonylglycine (NAGly)4 is an endogenous derivative of arachidonic acid that is produced in highest concentrations in the spinal cord [7]. Is a Noncompetitive Inhibitor of GLYT2—The aim of this study was to investigate the molecular basis for the differences in NAAA inhibition between the human glycine transporters GLYT1 and GLYT2.

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call